US FDA Establishment Inspections: Outcomes for Labelers for Homeopathic Drugs
By Mark Land, AAHP President, June 2016 Abstract Labelers of homeopathic drugs are a subset of drug manufacturing establishments located within the United States and internationally. Homeopathic drugs are regulated…
Read MoreUnderstanding OTC Monograph Reform: Where Do We Stand Now?
By J.P. Borneman, Ph.D. and Alvin J. Lorman, J.D. The FDA’s Over-the-Counter Drug Review (OTC Review) has always been important to homeopathy, despite the fact that homeopathic drugs are not…
Read MoreAdulterants in Your Botanical Source Materials – How Do You Know?
By Eric L. Foxman, R.Ph Many commercially available botanical products have been adulterated prior to their introduction to the market. This is a problem that has only recently come under…
Read MoreHomeopaths Without Borders Helps Haiti
Homeopaths Without Borders (HWB) has led 24 service trips to Haiti since 2010. With the help of volunteer homeopaths, individual donors, and homeopathic organizations and companies, they have been able…
Read MoreWebinar Review: FDA’s View on Compliance
On May 24, 2016, the American Association of Homeopathic Pharmacists hosted the latest in its Compliance through Education webinar series. The webinar featured a presentation from Brad Pace, acting director…
Read MoreFDA Guidance for Industry – Request for Quality Metrics
By Mark Land, AAHP President FDA published its draft guidance, Request for Quality Metrics; Guidance for Industry1. Advancing the background on the initiative in general, this draft reveals 10 mandatory…
Read MoreHomeopathic Drug Labels: Rx or OTC?
By J.P. Borneman, Ph.D. and Alvin J. Lorman Homeopathic drugs, we proudly tell folks, really are drugs: the Federal Food, Drug, and Cosmetic Act has recognized them as such since…
Read MoreDo Your Dosage Forms Appeal to Consumers?
By Eric L. Foxman, R.Ph. Consumers make purchase decisions based on several factors such as packaging and perceived effectiveness. Research shows dosage forms also factor into consumers’ decision to buy…
Read MoreLabeling homeopathic medicines for self-care
The U.S. Food and Drug Administration’s (FDA) electronic database of drug products contains more than 7,000 listings for over-the-counter (OTC) homeopathic products. The AAHP estimates that this number represents about…
Read MoreHatch, Paulsen Introduce Bill to Enhance HSA, FSA
In March, Senate Finance Committee Chairman Orrin Hatch (R-UT) and House Ways and Means Committee member, Rep. Erik Paulsen (R-MN) introduced the Health Savings Act of 2016. The Health Savings…
Read More